why choose us

First received: July 18, 2022

Clinical Trial: Vivity IOL: Emmetropia Compared to Monovision.

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Presbyopia

Study Type: Interventional


Official Title: Visual Outcomes, Patient Satisfaction and Spectacle Independence Evaluation of the Acrysof® IQ Vivity® Intraocular Lens Targeted for Emmetropia or Nanovision.

Brief Summary: Current visual outcomes expectations of cataract patients are similar to those of refractive surgery patients. Their desire is to be spectacle independent for far, intermediate and near vision activities. Different options are available including: mono-vision and presbyopia correcting intraocular lenses (IOL). Presbyopia correcting IOLs include accommodative, multifocal, trifocal and extended depth of focus (EDOF) IOLs. The Vivity Extended Vision IOL is not a multifocal IOL but due to its design, it provides…

Read more